Manufacturer record

Maan Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

11 batches manufactured by Maan Pharmaceuticals Ltd (Gujarat) were declared Not of Standard Quality between January 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

11 records linked to Maan Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
11Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2019 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

11
NSQ batches since 2019
10
Products affected
Dissolution
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2019 · 22021 · 12022 · 12023 · 22025 · 12026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ferric Carboxymaltose Injection 50 mg/ml RC26003Mfg 2026-01 · Exp 2027-12 The sample does not conform to Manufacturer's specification with respect to test for Particulate matter and Bacterial endotoxins.Particulate matter CDL, KolkataCDSCO lab Jul 2026
Ferric Carboxymaltose Injection 50 mg/ml RC25001Mfg 2025-09 · Exp 2027-08 The sample does not conform to Manufacturer's specification with respect to test for Bacterial endotoxinsBacterial endotoxins CDL, KolkataCDSCO lab May 2026
Fentanyl Citrate Injection I.P. FN25003Mfg 2025-10 · Exp 2027-09 The sample received does not conform to I.P. 2022 with respect to the test for Bacterial Endotoxin and Sterility.Sterility CDTL, MumbaiCDSCO lab Mar 2026
Amikacin Sulphate Injection IP AI25030Mfg 2025-12 · Exp 2027-11 The sample received does not conform to I.P. 2022 with respect to the test for Sterility.Sterility CDTL, MumbaiCDSCO lab Feb 2026
Colistimithate Sodium for Injection IP LT25001Mfg 2025-08 · Exp 2027-07 Bacterial EndotoxinsBacterial endotoxins Food & Drugs Laboratory, VadodaraState lab Nov 2025
Pantoprazole Tablets I.P. 40mg PNT/2300 IMfg 2023-05 · Exp 2025-04 Dissolution (Buffer stage)Dissolution CDTL MumbaiCDSCO lab Dec 2023
Cefotaxime for Injection IP 500 mg CD22002Mfg 2022-03 · Exp 2024-02 Particulate Matter & Clarity of SolutionParticulate matter CDL KolkataCDSCO lab Aug 2023
Iron Sucrose Injection U.S.P. IS20043Mfg 2020-10 · Exp 2022-09 Particulate Matter and Assay of IronAssay CDL KolkataCDSCO lab Aug 2022
IVERMECTIN TABLETS USP 6 Mg IVE/20002Mfg 2020-07 · Exp 2022-06 DissolutionDissolution RDTL ChandigarhCDSCO lab Jun 2021
MAANZEN CR 400 Tablets (Carbamazepine Controlled Release Tablets 400 mg) CCT/6005Mfg 2016-10 · Exp 2019-09 DissolutionDissolution CDSCO, Sub zone, BangaloreState lab Feb 2019
Ferrous Sulphate Tablets IP 200 mg IFT/8001Mfg 2018-03 · Exp 2020-02 AssayAssay CDTL MumbaiCDSCO lab Jan 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.